Marcus & Millichap vs Newmark
MMI and NMRK side by side, both in real estate. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MMI and NMRK compare
Newmark is the larger company, worth 2.0 times as much as Marcus & Millichap ($1.8B against $909M).
On earnings, Newmark is cheaper: it trades at 14.3× trailing earnings, against 64.9× for Marcus & Millichap.
Newmark grew revenue faster over the last twelve months (20.8% versus 11.9% for Marcus & Millichap).
Newmark keeps more of each dollar of sales as profit, with a net margin of 4.1% compared with 1.8% at Marcus & Millichap.
Both pay dividends: Marcus & Millichap yields 2.1% and Newmark 2.1%.
Newmark scores higher on the StockData Score (17 against 11 for Marcus & Millichap), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MMI | NMRK |
|---|---|---|
| Size and price | ||
| Market cap | $909M | $1.8B |
| Share price | $24.00 | $10.18 |
| Change, 1 year | −17.3% | −38.0% |
| Change, 5 years | −46.7% | −38.2% |
| Beta (5Y) | 0.08 | 0.42 |
| Employees | 854 | 8,800 |
| StockData Score | ||
| Total score | 11 | 17 (better) |
| Valuation score | 0 | 6 (better) |
| Growth score | 1 | 3 (better) |
| Performance score | 2 | 4 (better) |
| Health score | 6 (better) | 3 |
| Dividend score | 2 (better) | 1 |
| Valuation | ||
| P/E | 64.9× | 14.3× (better) |
| P/S | 1.1× | 0.5× (better) |
| P/B | 1.6× | 1.3× (better) |
| EV/EBITDA | 34.4× | 6.0× (better) |
| P/FCF | 10.8× | 2.3× (better) |
| PEG | – | 0.97 |
| FCF yield | 9.3% | 43.2% (better) |
| Fair value | $10.54 | $17.40 |
| Margin of safety | −128% | 41.5% (better) |
| Growth | ||
| Revenue growth (TTM) | 11.9% | 20.8% (better) |
| Revenue growth, 5Y average | 1.0% | 11.6% (better) |
| Net income growth (TTM) | – | 49.0% |
| EPS growth (TTM) | – | 65.1% |
| EPS growth, 5Y average | – | 11.8% |
| Profitability | ||
| Operating margin | 1.2% | 7.7% (better) |
| Net margin | 1.8% | 4.1% (better) |
| FCF margin | 10.4% | 22.1% (better) |
| Return on equity | 2.4% | 10.9% (better) |
| Return on invested capital | 1.5% | 10.2% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.60 (better) |
| Net debt / EBITDA | – | 1.32 |
| Interest coverage | 14.0× | – |
| Current ratio | 2.92 (better) | 1.09 |
| Altman Z-score | 4.99 (better) | 1.59 |
| Piotroski F-score | 5 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.1% (better) | 2.1% |
| Payout ratio | 142% | – |
| Years of dividend growth | – | 0 |
| Buyback yield | 4.8% | 8.3% (better) |
| Shareholder yield | 6.9% | 10.3% (better) |
| Ownership | ||
| Held by institutions | 60.4% | 64.6% |
| Held by insiders | 38.9% | 48.8% |
| Insider net buying, 12 months | −$48.5K | – |
| Short interest, % of float | 3.7% | 6.4% |
Go deeper
- MMI stock overview
- MMI income statement
- MMI valuation and score
- NMRK stock overview
- NMRK income statement
- NMRK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.